Cited by 160Genomics and Rare DiseasesMetabolism and Genetic DisordersConnective tissue disorders research

Meeting the challenges of implementing rapid genomic testing in acute pediatric care.

Open access
Stark, Zornitza, Lunke, Sebastian, Brett, Gemma R., Tan, Natalie B., Stapleton, Rachel, Kumble, Smitha, Yeung, Alison, Phelan, Dean G. +14 more·2018·Genetics in Medicine

Abstract

Purpose The purpose of the study was to implement and prospectively evaluate the outcomes of a rapid genomic diagnosis program at two pediatric tertiary centers.Methods Rapid singleton whole-exome sequencing (rWES) was performed in acutely unwell pediatric patients with suspected monogenic disorders. Laboratory and clinical barriers to implementation were addressed through continuous multidisciplinary review of process parameters. Diagnostic and clinical utility and cost-effectiveness of rWES were assessed.Results Of 40 enrolled patients, 21 (52.5%) received a diagnosis, with median time to report of 16 days (range 9-109 days). A result was provided during the first hospital admission in 28 of 36 inpatients (78%). Clinical management changed in 12 of the 21 diagnosed patients (57%), including the provision of lifesaving treatment, avoidance of invasive biopsies, and palliative care guidance. The cost per diagnosis was AU$13,388 (US$10,453). Additional cost savings from avoidance of planned tests and procedures and reduced length of stay are estimated to be around AU$543,178 (US$424,101). The clear relative advantage of rWES, joint clinical and laboratory leadership, and the creation of a multidisciplinary "rapid team" were key to successful implementation.Conclusion Rapid genomic testing in acute pediatrics is not only feasible but also cost-effective, and has high diagnostic and clinical utility. It requires a whole-of-system approach for successful implementation.

Integrity signals

Registry

Crossref · 10.1038/gim.2018.37

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stark, Z., Lunke, S., Brett, G. R., Tan, N. B., Stapleton, R., Kumble, S., Yeung, A., Phelan, D. G., Chong, B., Fanjul-Fernandez, M., Marum, J. E., Hunter, M., Jarmolowicz, A., Prawer, Y., Riseley, J. R., Regan, M., Elliott, J., Martyn, M., Best, S., Tan, T. Y., Gaff, C. L., & White, S. M.
Affiliations
  • The University of Melbourne (AU)
  • Victorian Clinical Genetics Services (AU)
  • Monash Children’s Hospital (AU)
  • Macquarie University (AU)
Corresponding author
Stark, Zornitza
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2018-12
Volume
20
Issue
12
Pages
1554-1563
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2793936903
Cited by
159
References
29
Citations by year
2026: 6 · 2025: 16 · 2024: 15 · 2023: 13 · 2022: 27 · 2021: 19 · 2020: 32 · 2019: 24 · 2018: 6 · 2012: 1
FWCI
12.42
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
Keywords
exome sequencing, monogenic disorders, diagnostic yield, time to diagnosis, cost-effectiveness, implementation barriers, clinical utility, length of hospital stay
MeSH terms
Exome Sequencing, Cost-Benefit Analysis, Female, Genetic Testing, Humans, Male, Pediatrics, Genome, Human, Genomics, Pathology, Molecular, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review